Camurus Financial Statements From 2010 to 2025
| CAMRF Stock | USD 69.70 5.48 8.53% |
Check Camurus AB financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Camurus AB's main balance sheet or income statement drivers, such as , as well as many indicators such as . Camurus financial statements analysis is a perfect complement when working with Camurus AB Valuation or Volatility modules.
Camurus |
Camurus AB OTC Stock Current Valuation Analysis
Camurus AB's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Camurus AB Current Valuation | 1.2 B |
Most of Camurus AB's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Camurus AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Camurus AB has a Current Valuation of 1.2 B. This is much higher than that of the sector and significantly higher than that of the Current Valuation industry. The current valuation for all United States stocks is notably lower than that of the firm.
Camurus AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Camurus AB's current stock value. Our valuation model uses many indicators to compare Camurus AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Camurus AB competition to find correlations between indicators driving Camurus AB's intrinsic value. More Info.Camurus AB is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Camurus AB's earnings, one of the primary drivers of an investment's value.About Camurus AB Financial Statements
Camurus AB stakeholders use historical fundamental indicators, such as Camurus AB's revenue or net income, to determine how well the company is positioned to perform in the future. Although Camurus AB investors may analyze each financial statement separately, they are all interrelated. For example, changes in Camurus AB's assets and liabilities are reflected in the revenues and expenses on Camurus AB's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Camurus AB. Please read more on our technical analysis and fundamental analysis pages.
Camurus AB , a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe, Australia, the United States, Japan, and internationally. Camurus AB was founded in 1991 and is headquartered in Lund, Sweden. Camurus Ab is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Camurus OTC Stock
Camurus AB financial ratios help investors to determine whether Camurus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Camurus with respect to the benefits of owning Camurus AB security.